Intravenous immunoglobulin for NMOSD

Intravenous immunoglobulin (IVIG) is a treatment that, while not approved for neuromyelitis optica spectrum disorder (NMOSD), is sometimes used off-label to treat NMOSD relapses when other strategies are ineffective.

In NMOSD, the immune system mistakenly launches inflammatory attacks on parts of the nervous system. Usually, these attacks are driven by self-reactive antibodies that target the aquaporin-4 protein. The disease often follows a relapsing course, with periods of relative stability interspersed with times of new or worsening symptoms (relapses) caused by active inflammation.

IVIG for NMOSD aims to reduce inflammation and harmful autoimmune activity. While some small studies suggest this could help control or prevent NMOSD relapses, the findings are mixed, so the approach is usually used when other treatments have not worked well enough.

What is IVIG?

IVIG contains pooled antibodies collected from thousands of donors that are delivered to the body via an intravenous, or into-the-vein, infusion.

Antibodies are proteins that enable the immune system to identify and attack harmful invaders, such as bacteria or viruses. In autoimmune diseases such as NMOSD, self-targeting antibodies mistakenly attack the body’s own tissues.

Researchers don’t entirely understand how IVIG works for autoimmune diseases, but it appears to have anti-inflammatory and immune-modulating effects. Scientists hypothesize that in NMOSD, IVIG may help decrease disease activity by:

  • Neutralizing self-reactive antibodies
  • Interfering with inflammatory signaling in immune cells

How IVIG is used in NMOSD

IVIG is not the standard treatment for NMOSD, but it is sometimes used off-label — or beyond its approved indications — to treat or prevent NMOSD relapses. There isn’t a standard IVIG dosage for NMOSD, and the treatment plan depends on the situation.

Standard management of an active NMOSD relapse involves high-dose corticosteroids, sometimes followed by plasma exchange therapy. A short course of IVIG may be considered in circumstances where other therapies are not sufficient to control the relapse. It may sometimes be combined with corticosteroids to boost the treatment response.

Off-label IVIG has also been studied as a long-term treatment for relapse prevention, and there is some limited evidence that regular infusions can reduce relapse rates. Specialists may consider IVIG maintenance therapy for NMOSD in children or people who can’t use standard medications to prevent relapses. It can also be used as an add-on to other maintenance therapies, but it may reduce the effectiveness of certain antibody-based treatments.

Scroll horizontally to view all columns -->

IVIG regimen When it may be used
 Short-term relapse control When other therapies, such as corticosteroids or plasma exchange, haven’t worked well enough to control a relapse
Long-term relapse prevention In children or people who can’t use standard relapse prevention therapies

Side effects

Although there is little evidence about IVIG side effects in NMOSD specifically, the therapy is generally considered safe. Common, mild side effects include:

  • Nausea
  • Vomiting
  • Headache
  • Fever
  • Chest pain
  • Back pain
  • Muscle pain

Other side effects may be more serious, but are rare. These include:

  • Hives and itchiness
  • Blood pressure changes (either low or high blood pressure)
  • Meningitis, or inflammation of the membranes that surround the brain and spinal cord
  • Shortness of breath
  • Kidney problems
  • Blood clots

The risks of IVIG are generally higher for older individuals. Doctors can help people with NMOSD weigh the potential risks and benefits of IVIG treatment when making a therapeutic plan. Patients should report any side effects to their healthcare providers.


Neuromyelitis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

FAQs about IVIG for NMOSD